INS and Hyperinsulinemia: The abundant evidence suggesting that IR and resultant hyperinsulinemia facilitate ovarian hyperandrogenism is central to the argument for the use of insulin sensitizers to treat adolescents with PCOS [122], when treatment might preclude adverse metabolic, reproductive and cardiovascular outcomes.